308 related articles for article (PubMed ID: 34620653)
1. Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation.
Al-Awadi A; Grove J; Taylor M; Valdes A; Vijay A; Bawden S; Gowland P; Aithal G
BMJ Open; 2021 Oct; 11(10):e045802. PubMed ID: 34620653
[TBL] [Abstract][Full Text] [Related]
2. Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: A randomized crossover study.
Bawden S; Stephenson M; Falcone Y; Lingaya M; Ciampi E; Hunter K; Bligh F; Schirra J; Taylor M; Morris P; Macdonald I; Gowland P; Marciani L; Aithal GP
Diabetes Obes Metab; 2017 Jan; 19(1):70-77. PubMed ID: 27593525
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
Parker A; Kim Y
Metab Syndr Relat Disord; 2019 Oct; 17(8):389-396. PubMed ID: 31305201
[TBL] [Abstract][Full Text] [Related]
5. Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial.
Dashti F; Alavian SM; Sohrabpour AA; Mousavi SE; Keshavarz SA; Esmaillzadeh A
BMJ Open; 2023 Apr; 13(4):e063988. PubMed ID: 37117000
[TBL] [Abstract][Full Text] [Related]
6. Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial.
Liu WY; Lu DJ; Du XM; Sun JQ; Ge J; Wang RW; Wang R; Zou J; Xu C; Ren J; Wen XF; Liu Y; Cheng SM; Tan X; Pekkala S; Munukka E; Wiklund P; Chen YQ; Gu Q; Xia ZC; Liu JJ; Liu WB; Chen XB; Zhang YM; Li R; Borra RJ; Yao JX; Chen PJ; Cheng S
BMC Public Health; 2014 Jan; 14():48. PubMed ID: 24438438
[TBL] [Abstract][Full Text] [Related]
7. Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease.
Scorletti E; Afolabi PR; Miles EA; Smith DE; Almehmadi A; Alshathry A; Moyses HE; Clough GF; Wright M; Patel J; Bindels L; Delzenne NM; Calder PC; Byrne CD
Contemp Clin Trials; 2018 Aug; 71():113-123. PubMed ID: 29787859
[TBL] [Abstract][Full Text] [Related]
8. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population.
Fava F; Gitau R; Griffin BA; Gibson GR; Tuohy KM; Lovegrove JA
Int J Obes (Lond); 2013 Feb; 37(2):216-23. PubMed ID: 22410962
[TBL] [Abstract][Full Text] [Related]
9. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
[TBL] [Abstract][Full Text] [Related]
10. Influence of habitual dietary fibre intake on the responsiveness of the gut microbiota to a prebiotic: protocol for a randomised, double-blind, placebo-controlled, cross-over, single-centre study.
Healey G; Brough L; Butts C; Murphy R; Whelan K; Coad J
BMJ Open; 2016 Sep; 6(9):e012504. PubMed ID: 27591024
[TBL] [Abstract][Full Text] [Related]
11. Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis.
Quesada-Vázquez S; Aragonès G; Del Bas JM; Escoté X
Cells; 2020 Jan; 9(1):. PubMed ID: 31936799
[TBL] [Abstract][Full Text] [Related]
12. Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial.
Rizkalla SW; Taghrid L; Laromiguiere M; Huet D; Boillot J; Rigoir A; Elgrably F; Slama G
Diabetes Care; 2004 Aug; 27(8):1866-72. PubMed ID: 15277409
[TBL] [Abstract][Full Text] [Related]
13. Liver fat as a dietary target by Chinese Medical Nutrition Therapy (CMNT) diet for treating type 2 diabetes with non-alcoholic fatty liver disease: study protocol for a randomised controlled trial.
Luo W; Xiao Z; Yang X; Wu R; Li J; Yu Z; Guo S; Nie B; Liu D
BMJ Open; 2024 Apr; 14(4):e081263. PubMed ID: 38684277
[TBL] [Abstract][Full Text] [Related]
14. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).
Elvira-Torales LI; Periago MJ; González-Barrio R; Hidalgo N; Navarro-González I; Gómez-Gallego C; Masuero D; Soini E; Vrhovsek U; García-Alonso FJ
Food Funct; 2019 Apr; 10(4):2148-2160. PubMed ID: 30938723
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
16. Does a high dietary intake of resistant starch affect glycaemic control and alter the gut microbiome in women with gestational diabetes? A randomised control trial protocol.
Latino C; Gianatti EJ; Mehta S; Lo J; Devine A; Christophersen C
BMC Pregnancy Childbirth; 2022 Jan; 22(1):46. PubMed ID: 35042457
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study.
Iwaki M; Kessoku T; Tanaka K; Ozaki A; Kasai Y; Yamamoto A; Takahashi K; Kobayashi T; Nogami A; Honda Y; Ogawa Y; Imajo K; Yoneda M; Kobayashi N; Saito S; Nakajima A
BMJ Open; 2022 Jul; 12(7):e060335. PubMed ID: 35820743
[TBL] [Abstract][Full Text] [Related]
18. A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients.
Calabrese FM; Disciglio V; Franco I; Sorino P; Bonfiglio C; Bianco A; Campanella A; Lippolis T; Pesole PL; Polignano M; Vacca M; Caponio GR; Giannelli G; De Angelis M; Osella AR
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565740
[TBL] [Abstract][Full Text] [Related]
19. A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease.
He K; Guo LL; Tang H; Peng X; Li J; Feng S; Bie C; Chen W; Li Y; Wang M; Tang S
Am J Gastroenterol; 2022 Oct; 117(10):1621-1631. PubMed ID: 35973188
[TBL] [Abstract][Full Text] [Related]
20. Effect of Dietary Glycemic Index on β-Cell Function in Prediabetes: A Randomized Controlled Feeding Study.
Sipe AT; Neuhouser ML; Breymeyer KL; Utzschneider KM
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
